iPSc-derived multi-cell-type therapy (Eterna Therapeutics/Factor Bioscience)

N/A

Report date: 2025/03/20 16:04:44

Base Information

Drug NameiPSc-derived multi-cell-type therapy (Eterna Therapeutics/Factor Bioscience)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFactor Bioscience Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A